Elevance Health Inc. closed $174.10 below its 52-week high ($567.26), which the company achieved on September 3rd.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Elevance Health (ELV – Research Report), Intuitive Surgical ...

In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Elevance Health (ELV – Research Report), with a ...

Shares of Elevance Health jumped early Thursday in response to better-than-expected fourth- quarter results, and a generally optimistic outlook for the coming year. A week after UnitedHealth Group ...

The latest trading week ended on a very sour note, given that the average stock in the broad-based Russell 3000 index declined 1.2% on Friday, even as the Dow Jones Industrial Average managed to ...

UnitedHealth beat fourth-quarter earnings forecast, though revenue fell short and medical costs ran high, hitting the Dow Jones component.

Shares of Elevance Health Inc. ELV slumped 0.69 ... with the S&P 500 Index SPX falling 1.11% to 5,970.84 and Dow Jones Industrial Average DJIA falling 0.77% to 42,992.21. The stock's fall snapped ...

Sources: FactSet, Dow Jones Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Sources: FactSet ...